TranscriptsBelgiumFeb. 28, 2026 12:47 AM ETUCB SA (UCBJY) Stock, UCBJF StockSA Transcripts158.7K FollowersCommentsUCB SA (UCBJY) Q4 2025 Earnings Call February 26, 2026 8:00 AM ESTCompany ParticipantsAntje Witte - Head of Investor RelationsJean-Christophe Tellier - CEO & Executive DirectorEmmanuel Caeymaex - Executive Vice President of Patient EvidenceFiona du Monceau - Executive VP & Chief Commercial OfficerSandrine Dufour - Executive VP, CFO & Chief Corporate DevelopmentConference Call ParticipantsPeter Verdult - BNP Paribas, Research DivisionStacy Ku - TD Cowen, Research DivisionNaresh ChouhanRichard Vosser - JPMorgan Chase & Co, Research DivisionXian Deng - UBS Investment Bank, Research DivisionRajan Sharma - Goldman Sachs Group, Inc., Research DivisionCharles Pitman - Barclays Bank PLC, Research DivisionSarita Kapila - Morgan Stanley, Research DivisionCharlie Haywood - BofA Securities, Research DivisionLuisa Hector - Joh. Berenberg, Gossler & Co. KG, Research DivisionPresentationAntje WitteHead of Investor RelationsWelcome to the UCB Full Year 2025 Capital Markets Call. My name is Antje, and I'm doing Investor Relations at UCB.Before I introduce you to the agenda and hand over to the speakers today, I have some remarks. This video is being recorded. You can find the presentation in our download center, if you dial in by the phone. The presentation and the following Q&A session are intended for institutional capital market participants only. If you're not, please disconnect now. This presentation and the following Q&A session are covered by the disclaimer and safe harbor statement as stated on Slide 2 of the slide deck. Kindly read this carefully.With this, I'd like you to introduce you to our speakers today: Jean-Christophe Tellier, our CEO; Emmanuel Caeymaex, Head of Patient Evidence; Fiona du Monceau, our Chief Commercial Officer; Sandrine Dufour, our CFO; and this will then be followed by a Q&A session with all presenters.Thank you. Jean-Christophe, over to you.Jean-Christophe TellierCEO & Executive DirectorThankRead more current UCBJY analysis and newsView all earnings call transcriptsComments